INTERNATIONAL PATENT: LA JOLLA INSTITUTE FOR IMMUNOLOGY FILES APPLICATION FOR "IMMUNE CELL-SPECIFIC PROTEIN DEGRADERS AND METHODS OF USE THEREOF FOR IMMUNOTHERAPY"

GENEVA, July 14 -- LA JOLLA INSTITUTE FOR IMMUNOLOGY (9420 Athena CircleLa Jolla, California 92037) filed a patent application (PCT/US2025/010316) for "IMMUNE CELL-SPECIFIC PROTEIN DEGRADERS AND METHODS OF USE THEREOF FOR IMMUNOTHERAPY" on Jan 03, 2025. With publication no. WO/2025/147671, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EHINGER, Erik (c/o La Jolla Institute of Immunology9420 Athena CircleLa Jolla, California 92037)

Abstract: Targeted protein degrader compounds, and methods of use thereof for targeted p...